High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
- PMID: 24164252
- DOI: 10.1111/cea.12225
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
Abstract
Background: Systemic mastocytosis (SM) is a clonal mast cells disorder characterized by the proliferation, accumulation and activation of mast cells in extracutaneous tissues. The clinical picture is heterogeneous and may range from asymptomatic to potentially fatal anaphylactic reactions due to excessive mast cell mediator release.
Objective: The aim of this study was to investigate the prevalence and trigger factors of anaphylactic reactions among adult SM patients. We also explored the clinical spectrum of mast cell mediator-related symptoms in patients with SM.
Methods: This descriptive study was performed among 84 consecutive adult (≥ 18 years) patients those were diagnosed with SM according to WHO criteria. Sixty-six of the patients also underwent a comprehensive allergy work-up.
Results: Sixty of 84 patients with SM (71%) had bone marrow mast cell aggregates and fulfilled the major criteria for SM and 76 patients (91%) had indolent disease. Simultaneous occurrence of cutaneous mastocytosis was observed in 59 patients (70%). Thirty-six patients (43%) had had at least one episode of an anaphylactic reaction. The clinical courses of the reactions were usually severe and patients often presented with syncope attacks (72%). Most patients reacted after hymenoptera venom stings (19/36; 53%). In 39% (14/36), a clear aetiology could not be determined. While males and females were equally frequent among the patients with SM, anaphylaxis patients showed a male predominance (61%). Anaphylactic reactions occurred more frequently in patients without cutaneous engagement. The rate of allergy sensitization was significantly higher in SM patients with anaphylaxis as compared with non-anaphylaxis SM patients, 70% vs. 23%, respectively (P = 0.0002).
Conclusions and clinical relevance: Anaphylaxis is more prevalent in patients with SM, predominantly in patients with atopic SM. Hymenoptera venom-induced and idiopathic anaphylaxis were the most frequent elicitors. Our findings implicate that all mastocytosis patients with anaphylaxis should undergo detailed allergological assessment before considering treatment and preventive measures.
Keywords: IgE sensitization; anaphylaxis; atopic disease; hymenoptera venom; mastocytosis; prevalence; tryptase.
© 2013 John Wiley & Sons Ltd.
Similar articles
-
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.J Allergy Clin Immunol. 2014 Feb;133(2):520-8. doi: 10.1016/j.jaci.2013.06.020. Epub 2013 Aug 6. J Allergy Clin Immunol. 2014. PMID: 23921094
-
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Immunotherapy. 2011 May;3(5):637-51. doi: 10.2217/imt.11.44. Immunotherapy. 2011. PMID: 21554093 Review.
-
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.J Allergy Clin Immunol. 2015 Jul;136(1):135-9. doi: 10.1016/j.jaci.2014.11.035. Epub 2015 Jan 17. J Allergy Clin Immunol. 2015. PMID: 25605272
-
The presence of mast cell clonality in patients with unexplained anaphylaxis.Clin Exp Allergy. 2014 Sep;44(9):1179-87. doi: 10.1111/cea.12369. Clin Exp Allergy. 2014. PMID: 25039926
-
Stinging Hymenoptera and mastocytosis.Curr Opin Allergy Clin Immunol. 2009 Aug;9(4):338-42. doi: 10.1097/ACI.0b013e32832d2bc7. Curr Opin Allergy Clin Immunol. 2009. PMID: 19474708 Review.
Cited by
-
Predictors of Clonality and Underlying Mastocytosis in Mast Cell Activation Syndromes.Curr Allergy Asthma Rep. 2024 Feb;24(2):25-32. doi: 10.1007/s11882-023-01122-w. Epub 2024 Jan 25. Curr Allergy Asthma Rep. 2024. PMID: 38270805 Review.
-
Using the Right Criteria for MCAS.Curr Allergy Asthma Rep. 2024 Feb;24(2):39-51. doi: 10.1007/s11882-024-01126-0. Epub 2024 Jan 20. Curr Allergy Asthma Rep. 2024. PMID: 38243020 Free PMC article. Review.
-
The diagnostic workup for systemic mastocytosis differs from consensus recommendations: Results of a worldwide survey.World Allergy Organ J. 2023 Nov 8;16(11):100838. doi: 10.1016/j.waojou.2023.100838. eCollection 2023 Nov. World Allergy Organ J. 2023. PMID: 38020286 Free PMC article.
-
A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis.Diagnostics (Basel). 2023 Oct 25;13(21):3307. doi: 10.3390/diagnostics13213307. Diagnostics (Basel). 2023. PMID: 37958203 Free PMC article. Review.
-
Perioperative management of mastocytosis.J Anesth. 2023 Oct;37(5):741-748. doi: 10.1007/s00540-023-03228-x. Epub 2023 Jul 19. J Anesth. 2023. PMID: 37466804 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
